Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 42

1.

Darunavir-based dual therapy in HIV experienced patients.

Sterrantino G, Zaccarelli M, Di Biagio A, Rosi A, Bruzzone B, Cicconi P, Carli T, Biondi ML, Antinori A, Bartolozzi D, Penco G.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19782. doi: 10.7448/IAS.17.4.19782. eCollection 2014.

2.

Efficacy and safety of darunavir/ritonavir plus etravirine dual regimen in antiretroviral therapy-experienced patients: a multicenter clinical experience.

Gazzola L, Cicconi P, Ripamonti D, Di Filippo E, Gustinetti G, Di Biagio A, Marchetti G, Bini T, d'Arminio Monforte A.

HIV Clin Trials. 2014 Jul-Aug;15(4):140-50. doi: 10.1310/hct1504-140.

PMID:
25143023
3.

Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients.

Lichtner M, Cicconi P, Vita S, Cozzi-Lepri A, Galli M, Lo Caputo S, Saracino A, De Luca A, Moioli M, Maggiolo F, Marchetti G, Vullo V, d'Arminio Monforte A; ICONA Foundation Study.

J Infect Dis. 2015 Jan 15;211(2):178-86. doi: 10.1093/infdis/jiu417. Epub 2014 Jul 31.

PMID:
25081936
4.

Inconsistent condom use among HIV-positive women in the "Treatment as Prevention Era": data from the Italian DIDI study.

Cicconi P, Monforte Ad, Castagna A, Quirino T, Alessandrini A, Gargiulo M, Francisci D, Anzalone E, Liuzzi G, Pierro P, Ammassari A; Didi Study Group.

J Int AIDS Soc. 2013 Oct 16;16:18591. doi: 10.7448/IAS.16.1.18591.

5.

Prevalence of prolonged amenorrhea in HIV-infected women: results from the Italian DIDI study.

Cicconi P, Ammassari A, Ladisa N, Di Sora F, Bini T, Pierro P, D'Ettorre G, Cattelan AM, Vichi F, Monforte AD; DIDI Study Group.

J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):e19-21. No abstract available.

PMID:
23007120
6.

Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort.

Di Biagio A, Prinapori R, Giannarelli D, Maggiolo F, Di Giambenedetto S, Borghi V, Penco G, Cicconi P, Francisci D, Sterrantino G, Zoncada A, Monno L, Capetti A, Giacometti A; ARCA Collaborative Group.

J Antimicrob Chemother. 2013 Jan;68(1):200-5. doi: 10.1093/jac/dks339. Epub 2012 Aug 21.

7.

Induced first abortion rates before and after HIV diagnosis: results of an Italian self-administered questionnaire survey carried out in 585 women living with HIV.

Ammassari A, Cicconi P, Ladisa N, Di Sora F, Bini T, Trotta MP, D'Ettorre G, Cattelan AM, Vichi F, d'Arminio Monforte A; DiDi Study Group.

HIV Med. 2013 Jan;14(1):31-9. doi: 10.1111/j.1468-1293.2012.01032.x. Epub 2012 Jun 26.

PMID:
22731856
8.

Detrimental effect of atazanavir plasma concentrations on total serum bilirubin levels in the presence of UGT1A1 polymorphisms.

Cicconi P, Bini T, Barassi A, Casana M, Turri O, Pateri F, Marchetti GC, Biondi ML, d'Eril GM, d'Arminio Manforte A.

J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):e96-7. doi: 10.1097/QAI.0b013e318203e7e7. No abstract available.

PMID:
21317582
9.

Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI.

Torti C, d'Arminio-Monforte A, Pozniak AL, Lapadula G, Cologni G, Antinori A, De Luca A, Mussini C, Castagna A, Cicconi P, Minoli L, Costantini A, Carosi G, Liang H, Cesana BM; MASTER, Chelsea & Westminster, ICONA, Modena and S. Raffaele HIV Cohorts.

BMC Infect Dis. 2011 Jan 25;11:23. doi: 10.1186/1471-2334-11-23.

10.

Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure.

Tordato F, Cozzi Lepri A, Cicconi P, De Luca A, Antinori A, Colangeli V, Castagna A, Nasta P, Ladisa N, Giacometti A, d'Arminio Monforte A, Gori A; ICONA Foundation Study Group.

HIV Med. 2011 Jan;12(1):4-13. doi: 10.1111/j.1468-1293.2010.00855.x.

PMID:
20584091
11.

Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients.

Cicconi P, Cozzi-Lepri A, Castagna A, Trecarichi EM, Antinori A, Gatti F, Cassola G, Sighinolfi L, Castelli P, d'Arminio Monforte A; ICoNA Foundation Study Group.

HIV Med. 2010 Feb;11(2):104-13. doi: 10.1111/j.1468-1293.2009.00750.x. Epub 2009 Sep 1.

PMID:
19732176
12.

Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features.

Morsica G, Ancarani F, Bagaglio S, Maracci M, Cicconi P, Cozzi Lepri A, Antonucci G, Bruno R, Santantonio T, Tacconi L, Baldelli F, Piscopo R, Santoro D, Lazzarin A, D'Arminio Monforte A; HepaICONA and the ICONA Study Groups.

Infection. 2009 Oct;37(5):445-9. doi: 10.1007/s15010-008-8194-9. Epub 2009 Aug 7.

PMID:
19669092
13.

Effectiveness of antiretroviral regimens containing abacavir with tenofovir in treatment-experienced patients: predictors of virological response and drug resistance evolution in a multi-cohort study.

Di Giambenedetto S, Torti C, Prosperi M, Manca N, Lapadula G, Paraninfo G, Ladisa N, Zazzi M, Trezzi M, Cicconi P, Corsi P, Nasta P, Cauda R, De Luca A; UCSC cohort; MASTER cohort; ARCA cohort.

Infection. 2009 Oct;37(5):438-44. doi: 10.1007/s15010-009-8237-x. Epub 2009 Aug 7.

PMID:
19669091
14.

Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients.

Morsica G, Bagaglio S, Cicconi P, Capobianchi MR, Pellizzer G, Caramello P, Orani A, Moioli C, Rizzardini G, Uberti-Foppa C, Puoti M, Monforte AD; Hepa I.C.o.N.A the Icona Foundation Study Groups.

J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):574-81. doi: 10.1097/QAI.0b013e3181add592.

PMID:
19590432
15.

Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy.

Zanone Poma B, Riva A, Nasi M, Cicconi P, Broggini V, Lepri AC, Mologni D, Mazzotta F, Monforte AD, Mussini C, Cossarizza A, Galli M; Icona Foundation Study Group.

AIDS. 2008 Sep 12;22(14):1769-78. doi: 10.1097/QAD.0b013e32830b3a96.

PMID:
18753860
16.

Vertebral fractures in AIDS patients within 6 months from highly active antiretroviral therapy initiation: two case reports.

Gazzola L, Bini T, Pietrogrande L, Uziel L, Cicconi P, Casana M, Monforte Ad.

AIDS. 2008 May 31;22(9):1094-7. doi: 10.1097/QAD.0b013e3282ffdea6. No abstract available.

PMID:
18520358
17.

Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis.

Cicconi P, Cozzi-lepri A, Orlando G, Matteelli A, Girardi E, Degli Esposti A, Moioli C, Rizzardini G, Chiodera A, Ballardini G, Tincati C, d'Arminio Monforte A; I.Co.N.A. Study Group.

Infection. 2008 Feb;36(1):46-53. doi: 10.1007/s15010-007-6300-z. Epub 2008 Jan 29.

PMID:
18231722
18.

Insulin resistance affects early virologic response in HIV-infected subjects treated for hepatitis C infection.

Bongiovanni M, Ranieri R, Casana M, Tordato F, Cicconi P, Tincati C, Bini T, Monforte Ad.

J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):258-9. doi: 10.1097/QAI.0b013e318158befd. No abstract available.

PMID:
18223362
19.

Observational study on HIV-infected subjects failing HAART receiving tenofovir plus didanosine as NRTI backbone.

Bongiovanni M, Gianotti N, Chiesa E, Nasta P, Cicconi P, Capetti A, di Biagio A, Matti A, Tirelli V, Marconi P, de Luca A, Mussini C, Gatti F, Zaccarelli M, Abeli C, Torti C, Antinori A, Castagna A, d'Arminio Monforte A.

Infection. 2007 Dec;35(6):451-6. Epub 2007 Nov 21.

PMID:
18034204
20.

Predictive factors of vascular intima media thickness in HIV-positive subjects.

Bongiovanni M, Casana M, Cicconi P, Pisacreta M, Codemo R, Pelucchi M, d'Arminio Monforte A, Bini T.

J Antimicrob Chemother. 2008 Jan;61(1):195-9. Epub 2007 Nov 12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk